National Cancer Institute; Notice of Closed Meeting, 8391-8392 [05-3156]

Download as PDF Federal Register / Vol. 70, No. 33 / Friday, February 18, 2005 / Notices Harlowton, Colorado Court of Federal Claims Number 04– 1005V 338. Rosemary and Jimmy Ayala on behalf of Jimmy Ayala, Jr. Philadelphia, Pennsylvania Court of Federal Claims Number 04– 1007V 339. Francine Jiminez and Albert Williams on behalf of Alsay Leday Williams Anaheim, California Court of Federal Claims Number 04– 1008V 340. Quiana Ferguson on behalf of Christopher Eugene Ferguson Dayton, Ohio Court of Federal Claims Number 04– 1009V 341. Sonya Tolentino on behalf of Nanea Tolentino, Deceased Kealakekua, Hawaii Court of Federal Claims Number 04– 1014V 342. Kimberly Dixon on behalf of Karl Coleman New Orleans, Louisiana Court of Federal Claims Number 04– 1022V 343. Terri and Oscar Finley on behalf of Donovan Finley New Orleans, Louisiana Court of Federal Claims Number 04– 1023V 344. Jacqueline and Steven Gilbert on behalf of Taylor Gilbert New Orleans, Louisiana Court of Federal Claims Number 04– 1024V 345. Sabrina and Clarence Toussaint on behalf of Allen Toussaint New Orleans, Louisiana Court of Federal Claims Number 04– 1025V 346. Lauren and David Mason on behalf of Sage Mason Limestone, Texas Court of Federal Claims Number 04– 1027V 347. Kathleen and Neil Doherty on behalf of Connor Doherty Woodburn, Massachusetts Court of Federal Claims Number 04– 1033V 348. Brenda and Ronald Knable on behalf of Paul Knable Chicago, Illinois Court of Federal Claims Number 04– 1034V 349. Thomas Bell on behalf of Annmarie Bell Suffolk, Virginia Court of Federal Claims Number 04– 1038V 350. Carla and Kevin Long on behalf of Colin James Long Vancouver, Washington Court of Federal Claims Number 04– 1039V VerDate jul<14>2003 15:41 Feb 17, 2005 Jkt 205001 351. Jennifer and Gary Stone on behalf of Amelia Stone Oshkosh, Wisconsin Court of Federal Claims Number 04– 1041V 352. Michele Siciliano on behalf of August Siciliano Ligonier, Pennsylvania Court of Federal Claims Number 04– 1054V 353. Ingrid Bianco on behalf of Greta Bianco Somers Point, New Jersey Court of Federal Claims Number 04– 1059V 354. Lonnie Vestal on behalf of Dakota Vestal Tyler, Texas Court of Federal Claims Number 04– 1063V 355. Amy Schlosser on behalf of Daniel Joseph Schlosser Tyler, Texas Court of Federal Claims Number 04– 1064V 356. Cheryl Thompson on behalf of Aaron Thompson Tyler, Texas Court of Federal Claims Number 04– 1065V 357. Theresa and Dale Conkel on behalf of Mark Conkel Richardson, Texas Court of Federal Claims Number 04– 1072V 358. Sonia and Hector Rosado on behalf of Hector Rosado Miami, Florida Court of Federal Claims Number 04– 1076V 359. Heather Hamilton on behalf of Logan Hamilton, Deceased Edmund, Oklahoma Court of Federal Claims Number 04– 1077V 360. Lori Quast on behalf of Steven Quast Mattoon, Illinois Court of Federal Claims Number 04– 1078V 361. Teresa and Steven Myers on behalf of Audrey Myers Charlotte, North Carolina Court of Federal Claims Number 04– 1079V 362. Katie Jaynes on behalf of Marcus Cetell Somers Point, New Jersey Court of Federal Claims Number 04– 1080V 363. Bruce Stearns Saint Croix Falls, Wisconsin Court of Federal Claims Number 04– 1082V 364. Cathleen and John Akers on behalf of John Henry Akers Houston, Texas Court of Federal Claims Number 04– 1083V PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 8391 365. Kelly and Josef Blake on behalf of Allisha Ray Blake Charleston, West Virginia Court of Federal Claims Number 04– 1084V 366. Tina Cockrell on behalf of Mark Andrew Carwell Mount Vernon, Ohio Court of Federal Claims Number 04– 1085V Dated: February 11, 2005. Elizabeth M. Duke, Administrator. [FR Doc. 05–3176 Filed 2–17–05; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel, Metabolomics for Early Cancer Detection. Date: March 22, 2005. Time: 1 p.m. to 4 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6116 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Thomas M. Vollberg, PhD, Scientific Review Administrator, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 7142, Bethesda, MD 20892, (301) 594–9582, volbert@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contract Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and E:\FR\FM\18FEN1.SGM 18FEN1 8392 Federal Register / Vol. 70, No. 33 / Friday, February 18, 2005 / Notices Diagnosis Research, 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: February 10, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–3156 Filed 2–17–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Complementary and Alternative Medicine; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Complementary and Alternative Medicine Special Emphasis Panel Training and Education. Date: March 7–8, 2005. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Laurie Friedman Donze, PhD, Scientific Review Administrator, National Center for Complement. & Alt. Medicine, National Institutes of Health, 6707 Democracy Blvd. Suite 401, Bethesda, MD 20892, (301) 402–1030, donzel2@mail.nih.gov. Dated: February 10, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–3169 Filed 2–17–05; 8:45 am] BILLING CODE 4140–01–M VerDate jul<14>2003 15:41 Feb 17, 2005 Jkt 205001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel Comprehensive International Program of Research on AIDS (CIPRA). Date: March 8–9, 2005. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Double Tree Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Eugene R. Baizman, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/ NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, (301) 402–1464. eb237e@nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel Food Allergy Research Consortium and Statistical Center. Date: March 14, 2005. Time: 11:30 a.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Bethesda, MD 20817. (Telephone conference call.) Contact Person: Gregory P. Jarosik, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/ NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, 301-496–0695. gjarosik@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS.) PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 Dated: February 11, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–3153 Filed 2–17–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Alcohol Abuse and Alcoholism Special Emphasis Panel, ZAA1 HH (31) PAR–03–133 Rapid Response to College Drinking Problems—U18 Applications. Date: March 4, 2005. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Holiday Inn Select Bethesda, 8120 Wisconsin Ave., Bethesda, MD 20814. Contact Person: Jeffrey I. Toward, PhD, Scientific Review Administrator, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, Extramural Project Review Branch, OEA, 5635 Fishers Lane, Room 3033, Bethesda, MD 20892–9304. (301) 435–5337. jtoward@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.271, Alcohol Research Career Development Awards for Scientists and Clinicians; 93.272, Alcohol National Research Service Awards for Research Training; 93.273, Alcohol Research Programs; 93.891, Alcohol Research Center Grants, National Institutes of Health, HHS.) Dated: February 11, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–3154 Filed 2–17–05; 8:45 am] BILLING CODE 4140–01–M E:\FR\FM\18FEN1.SGM 18FEN1

Agencies

[Federal Register Volume 70, Number 33 (Friday, February 18, 2005)]
[Notices]
[Pages 8391-8392]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-3156]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Metabolomics for Early Cancer Detection.
    Date: March 22, 2005.
    Time: 1 p.m. to 4 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Rockville, MD 20852, (Telephone Conference Call).
    Contact Person: Thomas M. Vollberg, PhD, Scientific Review 
Administrator, Special Review and Logistics Branch, Division of 
Extramural Activities, National Cancer Institute, 6116 Executive 
Blvd., Room 7142, Bethesda, MD 20892, (301) 594-9582, 
volbert@mail.nih.gov.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contract Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and

[[Page 8392]]

Diagnosis Research, 93.395, Cancer Treatment Research; 93.396, 
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, 
Cancer Research Manpower; 93.399, Cancer Control, National 
Institutes of Health, HHS)

    Dated: February 10, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-3156 Filed 2-17-05; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.